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To the Editor: Although urban 
cases of yellow fever have not been 
reported in Brazil since 1942, sylvatic 
yellow fever is still endemic to the 
northern and middle-western states. 
In the past decade, the endemic area 
has spread southward and eastward, 
approaching most populated states 
(1). In 2009, there was an outbreak 
of sylvatic yellow fever in São Paulo 
State that caused 28 cases and 11 
deaths. In the affected area, there had 
been no reports of yellow fever since 
the 1930s (2). In the outbreak setting, 
a case of perinatal yellow fever 
transmission was diagnosed. 
The mother was a 30-year-old 
woman exposed to yellow fever in 
late pregnancy in a sylvatic area near 
Piraju (23°11′44′′S, 49°22′54′′W), 
a city 100 km from Botucatu. The 
patient had not received yellow fever 
vaccine and had not traveled to yellow 
fever–endemic regions in the previous 
months. The exposure to yellow fever 
occurred during regular walks in a 
sylvatic area, a habit that continued 
until late pregnancy. She had fever, 
headache, and jaundice on March 14, 
2009. Three days later, on March 17, 
she delivered a female infant through 
vaginal partum in a hospital in her 
hometown. 
The mother´s symptoms 
were mild. She was admitted to 
Botucatu Medical School Hospital 
7 days after delivery; she had fever, 
jaundice, and conjunctival suffusion. 
Liver enzymes were elevated 
(aspartate aminotransferase [AST] 
246 U/L, alanine transaminase 
[ALT] 324 U/L, γ-glutamyl transpep-
tidase 221 U/L, and alkaline 
phosphatase 338 U/L). She was mildly 
anemic (hemoglobin level 10.2 g/dL), 
but leukocyte and platelet counts were 
within reference ranges. There were 
no other laboratory abnormalities. 
She was discharged after 7 days with 
complete recovery. 
The infant girl was born 
asymptomatic on March 17, with a 
birthweight of 3,800 g and Apgar 
scores of 9–10. She was discharged 
from the hospital after 2 days of 
exclusive breast-feeding. On the third 
day of life, she had fever and cyanosis 
and was readmitted to the local 
hospital with suspected pneumonia. 
She received antimicrobial drugs but 
showed no improvement. On the 8th 
day of life, she had hematemesis, 
melena, bleeding at venipuncture 
sites, hypoglycemia, and oliguria.
The newborn was transferred to 
the Neonatal Intensive Care Unit at 
Botucatu Medical School Hospital. 
At admission, she had hypotension, 
tachycardia, cutaneous paleness, 
jaundice, hepatomegaly, and melena. 
The initial diagnostic hypothesis was 
congenital or hospital-acquired sepsis, 
but the mother´s diagnosis prompted 
doctors to investigate possible yellow 
fever. The infant was intubated for 
ventilatory support and received 
volume expansion, vasoactive 
amines, antimicrobial drugs, blood 
components (erythrocytes, platelets, 
fresh frozen plasma, cryoprecipitate), 
and drugs to control bleeding. Liver 
enzymes values were initially high 
(AST 4,072 U/L, ALT 1,420 U/L) but 
fell abruptly within 3 days (AST 150 
U/L, ALT 114 U/L).
Despite the therapy, the 
newborn experienced liver and renal 
failure, disseminated intravascular 
coagulation, seizures, and fi nally 
coma. She died on the 12th day of 
life (4th day of hospitalization in the 
neonatal intensive care unit). Autopsy 
specimens showed massive liver 
necrosis, pulmonary hemorrhage, and 
acute tubular necrosis (Figure).
The mother had serologic tests 
(immunoglobulin M antibody capture 
ELISA) done on the 11th day of 
disease. Test results were positive for 
yellow fever and negative for dengue 
fever. The newborn had similar 
results from serum samples collected 
5 days after onset of symptoms with 
confi rmation by reverse transcription 
PCR (RT-PCR). RT-PCR was 
performed as described by Deubel et 
al. (3). Nucleotide sequencing showed 
a wild yellow fever virus belonging 
type I of South American genotype 
1E, according to the classifi cation 
proposed by Vasconcelos et al. (4). 
RT-PCR performed with samples of 
the mother´s serum did not amplify 
yellow fever virus sequences. 
However, the serum was collected on 
the 11th day post symptoms when the 
sensitivity of the test is low.
The vertical transmission of 
arboviruses has been documented. 
Pouliot et al. reviewed direct 
and indirect evidence for vertical 
transmission of dengue virus (5). 
Vertical transmission has also been 
reported for West Nile encephalitis and 
western equine encephalitis (6). This is 
not the case for yellow fever. Reports 
of yellow fever during pregnancy 
are scarce (7), and we found none 
that describe vertical transmission to 
newborns. However, vaccine virus 
was isolated from asymptomatic 
newborns from pregnant women who 
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were inadvertently administered 17D 
vaccines (8). Still, mother-to-child 
transmission in late pregnancy or 
during delivery is a likely explanation 
for this newborn infection. The 
possibility of acquiring the virus 
through a mosquito bite is unlikely 
because urban cases of yellow fever 
have not occurred in Brazil in the past 
50 years and were not reported in the 
present outbreak. 
The timing of the newborn’s 
symptoms also argues against the 
possibility of transmission from 
a mosquito. We cannot rule out 
transmission through breast-feeding, 
which has been reported for the yellow 
fever vaccine virus (9). However, this 
would presuppose a short incubation 
period. In conclusion, this case points 
out to the possibility of vertical 
transmission of yellow fever. We 
imagine that similar cases can occur 
in yellow fever–endemic settings 
and may be identifi ed by improved 
surveillance.
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Figure. Microscopy fi ndings of autopsy specimens from a 12-day-old girl with yellow fever, 
Brazil, 2009. A) Massive liver necrosis, with proliferation of ductular-like structures around 
portal tracts (arrow); B) hepatocytes with microvesicular fatty changes (arrows); C) intra-
alveolar lung hemorrhage (arrows); D) renal tissue showing acute tubular necrosis (arrows). 
Panels A and C, original magnifi cation ×200; panels B and D, original magnifi cation ×400. 
A color version of this fi gure is available online (www.cdc.gov/EID/content/17/9/110242-F.
htm).
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